Chi Van Dang, M.D., Ph.D. - Publications

Abramson Cancer Center University of Pennsylvania, Philadelphia, PA, United States 
Cancer metabolism

235 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Supplee JG, Affronti HC, Duan R, Brooks RC, Stine ZE, Nguyen PTT, Pinheiro LV, Noji MC, Drummond JM, Huang K, Schultz K, Dang CV, Marmorstein R, Wellen KE. ACLY alternative splicing correlates with cancer phenotypes. The Journal of Biological Chemistry. 107418. PMID 38815867 DOI: 10.1016/j.jbc.2024.107418  0.348
2024 Zhang X, Pant SM, Ritch CC, Tang HY, Shao H, Dweep H, Gong YY, Brooks R, Brafford P, Wolpaw AJ, Lee Y, Weeraratna A, Sehgal A, Herlyn M, Kossenkov A, ... ... Dang CV, et al. Cell state dependent effects of Bmal1 on melanoma immunity and tumorigenicity. Nature Communications. 15: 633. PMID 38245503 DOI: 10.1038/s41467-024-44778-2  0.329
2023 Iascone DM, Zhang X, Bafford P, Mesaros C, Sela Y, Hofbauer S, Zhang SL, Cook K, Pivarshev P, Stanger BZ, Anderson S, Dang CV, Sehgal A. Hypermetabolic state is associated with circadian rhythm disruption in mouse and human cancer cells. Biorxiv : the Preprint Server For Biology. PMID 38014131 DOI: 10.1101/2023.11.08.566310  0.362
2023 Cazarin J, DeRollo RE, Shahidan SNABA, Burchett JB, Mwangi D, Krishnaiah S, Hsieh AL, Walton ZE, Brooks R, Mello SS, Weljie AM, Dang CV, Altman BJ. MYC disrupts transcriptional and metabolic circadian oscillations in cancer and promotes enhanced biosynthesis. Plos Genetics. 19: e1010904. PMID 37639465 DOI: 10.1371/journal.pgen.1010904  0.779
2023 Dang CV. Cancer Metabolism Historical Perspectives: A Chronicle of Controversies and Consensus. Cold Spring Harbor Perspectives in Medicine. PMID 37553212 DOI: 10.1101/cshperspect.a041530  0.37
2023 DeRollo RE, Cazarin J, Ahmad Shahidan SNAB, Burchett JB, Mwangi D, Krishnaiah S, Hsieh AL, Walton ZE, Brooks R, Mello SS, Weljie AM, Dang CV, Altman BJ. MYC disrupts transcriptional and metabolic circadian oscillations in cancer and promotes enhanced biosynthesis. Biorxiv : the Preprint Server For Biology. PMID 36711638 DOI: 10.1101/2023.01.03.522637  0.778
2022 Afzal J, Suhail Y, Chang H, Hubbi ME, Hamidzadeh A, Goyal R, Liu Y, Sun P, Nicoli S, Dang CV, Levchenko A. Lactate-dependent chaperone-mediated autophagy induces oscillatory HIF-1α activity promoting proliferation of hypoxic cells. Cell Systems. PMID 36462504 DOI: 10.1016/j.cels.2022.11.003  0.318
2022 Brooks R, Monzy J, Aaron B, Zhang X, Kossenkov A, Hayden J, Keeney F, Speicher DW, Zhang L, Dang CV. Circadian lncRNA ADIRF-AS1 binds PBAF and regulates renal clear cell tumorigenesis. Cell Reports. 41: 111514. PMID 36261012 DOI: 10.1016/j.celrep.2022.111514  0.313
2022 Sela Y, Li J, Maheswaran S, Norgard RJ, Yuan S, Hubbi ME, Doepner M, Xu JP, Ho ES, Mesaros C, Sheehan C, Croley G, Muir A, Blair IA, Shalem O, ... Dang CV, et al. Bcl-xL enforces a slow-cycling state necessary for survival in the nutrient-deprived microenvironment of pancreatic cancer. Cancer Research. PMID 35315913 DOI: 10.1158/0008-5472.CAN-22-0431  0.416
2021 Stine ZE, Schug ZT, Salvino JM, Dang CV. Targeting cancer metabolism in the era of precision oncology. Nature Reviews. Drug Discovery. PMID 34862480 DOI: 10.1038/s41573-021-00339-6  0.353
2021 Harrington CT, Sotillo E, Dang CV, Thomas-Tikhonenko A. Tilting MYC toward cancer cell death. Trends in Cancer. PMID 34481764 DOI: 10.1016/j.trecan.2021.08.002  0.684
2021 Tang HY, Goldman AR, Zhang X, Speicher DW, Dang CV. Measuring MYC-Mediated Metabolism in Tumorigenesis. Methods in Molecular Biology (Clifton, N.J.). 2318: 231-239. PMID 34019293 DOI: 10.1007/978-1-0716-1476-1_11  0.386
2021 Wolpaw AJ, Bayliss R, Büchel G, Dang CV, Eilers M, Gustafson WC, Hansen GM, Jura N, Knapp S, Lemmon MA, Levens D, Maris JM, Marmorstein R, Metallo SJ, Park JR, et al. Drugging the 'undruggable' MYCN oncogenic transcription factor: Overcoming previous obstacles to impact childhood cancers. Cancer Research. PMID 33509943 DOI: 10.1158/0008-5472.CAN-20-3108  0.515
2020 Rai G, Urban DJ, Mott BT, Hu X, Yang SM, Benavides GA, Johnson MS, Squadrito GL, Brimacombe KR, Lee TD, Cheff DM, Zhu H, Henderson MJ, Pohida K, Sulikowski GA, ... ... Dang CV, et al. Pyrazole-Based Lactate Dehydrogenase (LDH) Inhibitors with Optimized Cell Activity and Pharmacokinetic Properties. Journal of Medicinal Chemistry. PMID 32902275 DOI: 10.1021/Acs.Jmedchem.0C00916  0.378
2020 Oshima N, Ishida R, Kishimoto S, Beebe K, Brender JR, Yamamoto K, Urban D, Rai G, Johnson MS, Benavides G, Squadrito GL, Crooks D, Jackson J, Joshi A, Mott BT, ... ... Dang CV, et al. Dynamic Imaging of LDH Inhibition in Tumors Reveals Rapid In Vivo Metabolic Rewiring and Vulnerability to Combination Therapy. Cell Reports. 30: 1798-1810.e4. PMID 32049011 DOI: 10.1016/J.Celrep.2020.01.039  0.317
2020 Dang CV, Kim JW. Convergence of Cancer Metabolism and Immunity: an Overview. Biomolecules & Therapeutics. 26: 4-9. PMID 29212301 DOI: 10.4062/biomolther.2017.194  0.398
2019 Harrington CT, Sotillo E, Robert A, Hayer KE, Bogusz AM, Psathas J, Yu D, Taylor D, Dang CV, Klein PS, Hogarty MD, Geoerger B, El-Deiry WS, Wiels J, Thomas-Tikhonenko A. Correction: Transient stabilization, rather than inhibition, of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma. Leukemia. PMID 31758088 DOI: 10.1038/S41375-019-0650-2  0.585
2019 Hsieh AL, Zheng X, Yue Z, Stine ZE, Mancuso A, Rhoades SD, Brooks R, Weljie AM, Eisenman RN, Sehgal A, Dang CV. Misregulation of Drosophila Myc Disrupts Circadian Behavior and Metabolism. Cell Reports. 29: 1778-1788.e4. PMID 31722196 DOI: 10.1016/J.Celrep.2019.10.022  0.748
2019 Gouw AM, Margulis K, Liu NS, Raman SJ, Mancuso A, Toal GG, Tong L, Mosley A, Hsieh AL, Sullivan DK, Stine ZE, Altman BJ, Schulze A, Dang CV, Zare RN, et al. The MYC Oncogene Cooperates with Sterol-Regulated Element-Binding Protein to Regulate Lipogenesis Essential for Neoplastic Growth. Cell Metabolism. PMID 31447321 DOI: 10.1016/J.Cmet.2019.07.012  0.816
2019 Agarwal E, Altman BJ, Seo JH, Ghosh JC, Kossenkov AV, Tang HY, Krishn SR, Languino LR, Gabrilovich DI, Speicher DW, Dang CV, Altieri DC. Myc-mediated transcriptional regulation of the mitochondrial chaperone TRAP1 controls primary and metastatic tumor growth. The Journal of Biological Chemistry. PMID 31097545 DOI: 10.1074/Jbc.Ac119.008656  0.373
2019 Harrington CT, Sotillo E, Robert A, Hayer KE, Bogusz AM, Psathas J, Yu D, Taylor D, Dang CV, Klein P, Hogarty MD, Geoerger B, El-Deiry WS, Wiels J, Thomas-Tikhonenko A. Transient stabilization, rather than inhibition, of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma. Leukemia. PMID 30914792 DOI: 10.1038/s41375-019-0454-4  0.641
2018 Dang CV. Cancer Metabolism: the Known, Unknowns. Biochimica Et Biophysica Acta. Reviews On Cancer. 1870: 1. PMID 30336841 DOI: 10.1016/j.bbcan.2018.07.006  0.321
2018 Walton ZE, Patel CH, Brooks RC, Yu Y, Ibrahim-Hashim A, Riddle M, Porcu A, Jiang T, Ecker BL, Tameire F, Koumenis C, Weeraratna AT, Welsh DK, Gillies R, Alwine JC, ... ... Dang CV, et al. Acid Suspends the Circadian Clock in Hypoxia through Inhibition of mTOR. Cell. PMID 29861175 DOI: 10.1016/J.Cell.2018.05.009  0.45
2018 Wolpaw AJ, Dang CV. MYC-induced metabolic stress and tumorigenesis. Biochimica Et Biophysica Acta. PMID 29791870 DOI: 10.1016/J.Bbcan.2018.05.003  0.301
2018 Xie H, Tang CA, Song JH, Mancuso A, Valle JRD, Cao J, Xiang Y, Dang CV, Lan R, Sanchez DJ, Keith B, Hu CA, Simon MC. IRE1α RNase-dependent lipid homeostasis promotes survival in Myc-transformed cancers. The Journal of Clinical Investigation. PMID 29381485 DOI: 10.1172/Jci95864  0.498
2017 Bu Y, Yoshida A, Chitnis N, Altman BJ, Tameire F, Oran A, Gennaro V, Armeson KE, McMahon SB, Wertheim GB, Dang CV, Ruggero D, Koumenis C, Fuchs SY, Diehl JA. A PERK-miR-211 axis suppresses circadian regulators and protein synthesis to promote cancer cell survival. Nature Cell Biology. PMID 29230015 DOI: 10.1038/S41556-017-0006-Y  0.411
2017 Wolpaw AJ, Dang CV. Exploiting Metabolic Vulnerabilities of Cancer with Precision and Accuracy. Trends in Cell Biology. PMID 29229182 DOI: 10.1016/J.Tcb.2017.11.006  0.363
2017 Lu Y, Hu Z, Mangala LS, Stine ZE, Hu X, Jiang D, Xiang Y, Zhang Y, Pradeep S, Rodriguez-Aguayo C, Lopez-Berestein G, Demarzo A, Sood AK, Zhang L, Dang CV. MYC targeted long non-coding RNA DANCR promotes cancer in part by reducing p21 levels. Cancer Research. PMID 29180471 DOI: 10.1158/0008-5472.Can-17-0815  0.815
2017 Rai G, Brimacombe KR, Mott BT, Urban DJ, Hu X, Yang SM, Lee TD, Cheff DM, Kouznetsova J, Benavides GA, Pohida K, Kuenstner EJ, Luci DK, Lukacs CM, Davies DR, ... ... Dang CV, et al. Discovery and Optimization of Potent, Cell-Active Pyrazole-Based Inhibitors of Lactate Dehydrogenase (LDH). Journal of Medicinal Chemistry. PMID 29120638 DOI: 10.1021/Acs.Jmedchem.7B00941  0.374
2017 Yang L, Zhang Y, Shan W, Hu Z, Yuan J, Pi J, Wang Y, Fan L, Tang Z, Li C, Hu X, Tanyi JL, Fan Y, Huang Q, Montone K, ... Dang CV, et al. Repression of BET activity sensitizes homologous recombination-proficient cancers to PARP inhibition. Science Translational Medicine. 9. PMID 28747513 DOI: 10.1126/Scitranslmed.Aal1645  0.441
2017 Dang CV, Reddy EP, Shokat KM, Soucek L. Drugging the 'undruggable' cancer targets. Nature Reviews. Cancer. PMID 28643779 DOI: 10.1038/Nrc.2017.36  0.321
2017 Rajeshkumar NV, Yabuuchi S, Pai S, De Oliveira E, Kamphorst JJ, Rabinowitz JD, Tejero H, Al-Shahrour F, Hidalgo M, Maitra A, Dang CV. Treatment of pancreatic cancer patient-derived xenograft panel with metabolic inhibitors reveals efficacy of phenformin. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 28611197 DOI: 10.1158/1078-0432.Ccr-17-1115  0.38
2017 Dang CV. c-MYC mRNA tail tale about glutamine control of transcription. The Embo Journal. PMID 28507224 DOI: 10.15252/Embj.201796999  0.411
2017 Krishnaiah SY, Wu G, Altman BJ, Growe J, Rhoades SD, Coldren F, Venkataraman A, Olarerin-George AO, Francey LJ, Mukherjee S, Girish S, Selby CP, Cal S, Er U, Sianati B, ... ... Dang CV, et al. Clock Regulation of Metabolites Reveals Coupling between Transcription and Metabolism. Cell Metabolism. 25: 1206. PMID 28467936 DOI: 10.1016/J.Cmet.2017.04.023  0.388
2017 Krishnaiah SY, Wu G, Altman BJ, Growe J, Rhoades SD, Coldren F, Venkataraman A, Olarerin-George AO, Francey LJ, Mukherjee S, Girish S, Selby CP, Cal S, Er U, Sianati B, ... ... Dang CV, et al. Clock Regulation of Metabolites Reveals Coupling between Transcription and Metabolism. Cell Metabolism. 25: 961-974.e4. PMID 28380384 DOI: 10.1016/J.Cmet.2017.03.019  0.395
2017 Borazanci E, Dang CV, Robey RW, Bates SE, Chabot JA, Von Hoff DD. Pancreatic Cancer: "A Riddle Wrapped in a Mystery inside an Enigma". Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 23: 1629-1637. PMID 28373361 DOI: 10.1158/1078-0432.Ccr-16-2070  0.406
2017 Altman BJ, Hsieh AL, Gouw AM, Dang CV. Correspondence: Oncogenic MYC persistently upregulates the molecular clock component REV-ERBα. Nature Communications. 8: 14862. PMID 28332504 DOI: 10.1038/Ncomms14862  0.767
2017 Dang CV. A Time for MYC: Metabolism and Therapy. Cold Spring Harbor Symposia On Quantitative Biology. PMID 28174256 DOI: 10.1101/Sqb.2016.81.031153  0.536
2016 Altman BJ, Stine ZE, Dang CV. From Krebs to clinic: glutamine metabolism to cancer therapy. Nature Reviews. Cancer. 16: 773. PMID 28704359 DOI: 10.1038/Nrc.2016.131  0.383
2016 Xu Q, Zhang Q, Ishida Y, Hajjar S, Tang X, Shi H, Dang CV, Le AD. EGF induces epithelial-mesenchymal transition and cancer stem-like cell properties in human oral cancer cells via promoting Warburg effect. Oncotarget. PMID 27926487 DOI: 10.18632/Oncotarget.13771  0.456
2016 Huang, Li T, Wang L, Zhang L, Yan R, Li K, Xing S, Wu G, Hu L, Jia W, Lin SC, Dang CV, Song L, Gao P, Zhang H. Hepatocellular carcinoma redirects to ketolysis for progression under nutrition deprivation stress. Cell Research. PMID 27644987 DOI: 10.1038/Cr.2016.109  0.344
2016 Hsieh AL, Dang CV. MYC, Metabolic Synthetic Lethality, and Cancer. Recent Results in Cancer Research. Fortschritte Der Krebsforschung. ProgrèS Dans Les Recherches Sur Le Cancer. 207: 73-91. PMID 27557535 DOI: 10.1007/978-3-319-42118-6_4  0.798
2016 Altman BJ, Stine ZE, Dang CV. From Krebs to clinic: glutamine metabolism to cancer therapy. Nature Reviews. Cancer. PMID 27492215 DOI: 10.1038/Nrc.2016.71  0.447
2016 Zhang Y, He Q, Hu Z, Feng Y, Fan L, Tang Z, Yuan J, Shan W, Li C, Hu X, Tanyi JL, Fan Y, Huang Q, Montone K, Dang CV, et al. Long noncoding RNA LINP1 regulates repair of DNA double-strand breaks in triple-negative breast cancer. Nature Structural & Molecular Biology. PMID 27111890 DOI: 10.1038/Nsmb.3211  0.343
2016 Dang CV. Abstract SY12-03: MYC-mediated metabolic vulnerabilities and the circadian clock Cancer Research. 76. DOI: 10.1158/1538-7445.Am2016-Sy12-03  0.556
2016 Stine Z, Walton ZE, Zhang L, Fan TM, Lane AN, Dang CV. Abstract 2669: Glutaminase alternative splicing controls tumor growth and metabolism Cancer Research. 76: 2669-2669. DOI: 10.1158/1538-7445.Am2016-2669  0.466
2015 Stine ZE, Dang CV. Q-ing tumor glutaminase for therapy. Oncotarget. PMID 26564960 DOI: 10.18632/Oncotarget.6301  0.51
2015 Yan X, Hu Z, Feng Y, Hu X, Yuan J, Zhao SD, Zhang Y, Yang L, Shan W, He Q, Fan L, Kandalaft LE, Tanyi JL, Li C, Yuan CX, ... ... Dang CV, et al. Comprehensive Genomic Characterization of Long Non-coding RNAs across Human Cancers. Cancer Cell. 28: 529-40. PMID 26461095 DOI: 10.1016/J.Ccell.2015.09.006  0.374
2015 Matkar S, Sharma P, Gao S, Gurung B, Katona BW, Liao J, Muhammad AB, Kong XC, Wang L, Jin G, Dang CV, Hua X. An Epigenetic Pathway Regulates Sensitivity of Breast Cancer Cells to HER2 Inhibition via FOXO/c-Myc Axis. Cancer Cell. 28: 472-85. PMID 26461093 DOI: 10.1016/J.Ccell.2015.09.005  0.479
2015 Stine ZE, Dang CV. Splicing and Dicing MYC-Mediated Synthetic Lethality. Cancer Cell. 28: 405-6. PMID 26461086 DOI: 10.1016/J.Ccell.2015.09.016  0.417
2015 Altman BJ, Hsieh AL, Sengupta A, Krishnanaiah SY, Stine ZE, Walton ZE, Gouw AM, Venkataraman A, Li B, Goraksha-Hicks P, Diskin SJ, Bellovin DI, Simon MC, Rathmell JC, Lazar MA, ... ... Dang CV, et al. MYC Disrupts the Circadian Clock and Metabolism in Cancer Cells. Cell Metabolism. 22: 1009-19. PMID 26387865 DOI: 10.1016/J.Cmet.2015.09.003  0.82
2015 Stine ZE, Walton ZE, Altman BJ, Hsieh AL, Dang CV. MYC, Metabolism, and Cancer. Cancer Discovery. 5: 1024-39. PMID 26382145 DOI: 10.1158/2159-8290.Cd-15-0507  0.806
2015 Hsieh AL, Walton ZE, Altman BJ, Stine ZE, Dang CV. MYC and metabolism on the path to cancer. Seminars in Cell & Developmental Biology. PMID 26277543 DOI: 10.1016/J.Semcdb.2015.08.003  0.784
2015 Dang MT, Wehrli S, Dang CV, Curran T. The Ketogenic Diet Does Not Affect Growth of Hedgehog Pathway Medulloblastoma in Mice. Plos One. 10: e0133633. PMID 26192445 DOI: 10.1371/Journal.Pone.0133633  0.352
2015 Rajeshkumar NV, Dutta P, Yabuuchi S, de Wilde RF, Matrinez GV, Le A, Kamphorst JJ, Rabinowitz JD, Jain SK, Hidalgo M, Dang CV, Gillies RJ, Maitra A. Therapeutic targeting of the Warburg effect in pancreatic cancer relies on an absence of p53 function. Cancer Research. PMID 26113084 DOI: 10.1158/0008-5472.Can-15-0108  0.463
2015 Shroff EH, Eberlin LS, Dang VM, Gouw AM, Gabay M, Adam SJ, Bellovin DI, Tran PT, Philbrick WM, Garcia-Ocana A, Casey SC, Li Y, Dang CV, Zare RN, Felsher DW. MYC oncogene overexpression drives renal cell carcinoma in a mouse model through glutamine metabolism. Proceedings of the National Academy of Sciences of the United States of America. 112: 6539-44. PMID 25964345 DOI: 10.1073/Pnas.1507228112  0.656
2015 Xiang Y, Stine ZE, Xia J, Lu Y, O'Connor RS, Altman BJ, Hsieh AL, Gouw AM, Thomas AG, Gao P, Sun L, Song L, Yan B, Slusher BS, Zhuo J, ... ... Dang CV, et al. Targeted inhibition of tumor-specific glutaminase diminishes cell-autonomous tumorigenesis. The Journal of Clinical Investigation. 125: 2293-306. PMID 25915584 DOI: 10.1172/Jci75836  0.792
2015 Korangath P, Teo WW, Sadik H, Han L, Mori N, Huijts CM, Wildes F, Bharti S, Zhang Z, Santa-Maria CA, Tsai H, Dang CV, Stearns V, Bhujwalla ZM, Sukumar S. Targeting Glutamine Metabolism in Breast Cancer with Aminooxyacetate. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 21: 3263-73. PMID 25813021 DOI: 10.1158/1078-0432.Ccr-14-1200  0.405
2015 Dang CV. Web of the Extended Myc Network Captures Metabolism for Tumorigenesis Cancer Cell. 27: 160-162. PMID 25670077 DOI: 10.1016/J.Ccell.2015.01.004  0.441
2015 Stine ZE, Walton ZE, Altman BJ, Hsieh AL, Dang CV. MYC, metabolism, and cancer Cancer Discovery. 5: 1024-1039. DOI: 10.1158/2159-8290.CD-15-0507  0.751
2015 Altman BJ, Stine ZE, Hsieh AL, Deberardinis RJ, Dang CV. Abstract 4708: Mammalian glutamine metabolism controls circadian rhythm through regulation of reactive oxygen species Cancer Research. 75: 4708-4708. DOI: 10.1158/1538-7445.Am2015-4708  0.778
2015 Dang CV. A metabolic perspective of peto’s paradox and cancer Philosophical Transactions of the Royal Society B: Biological Sciences. 370. DOI: 10.1098/rstb.2014.0223  0.313
2015 Gouw AM, Hsieh AL, Stine ZE, Dang CV. MYC regulation of metabolism and cancer Tumor Cell Metabolism: Pathways, Regulation and Biology. 101-122. DOI: 10.1007/978-3-7091-1824-5_5  0.802
2014 Le A, Stine ZE, Nguyen C, Afzal J, Sun P, Hamaker M, Siegel NM, Gouw AM, Kang BH, Yu SH, Cochran RL, Sailor KA, Song H, Dang CV. Tumorigenicity of hypoxic respiring cancer cells revealed by a hypoxia-cell cycle dual reporter. Proceedings of the National Academy of Sciences of the United States of America. 111: 12486-91. PMID 25114222 DOI: 10.1073/Pnas.1402012111  0.674
2014 Dang CV. Gene regulation: Fine-tuned amplification in cells Nature. 511: 417-418. PMID 25043013 DOI: 10.1038/Nature13518  0.429
2014 Emadi A, Jun SA, Tsukamoto T, Fathi AT, Minden MD, Dang CV. Inhibition of glutaminase selectively suppresses the growth of primary acute myeloid leukemia cells with IDH mutations. Experimental Hematology. 42: 247-51. PMID 24333121 DOI: 10.1016/J.Exphem.2013.12.001  0.437
2014 Doherty JR, Yang C, Scott KE, Cameron MD, Fallahi M, Li W, Hall MA, Amelio AL, Mishra JK, Li F, Tortosa M, Genau HM, Rounbehler RJ, Lu Y, Dang CV, et al. Blocking lactate export by inhibiting the Myc target MCT1 Disables glycolysis and glutathione synthesis. Cancer Research. 74: 908-20. PMID 24285728 DOI: 10.1158/0008-5472.Can-13-2034  0.808
2014 Fan T, Le A, Stine Z, Yang Y, Zeller K, Zhou W, Ji H, Higashi R, Dang C, Lane A. Antagonistic effects of MYC and hypoxia in channeling glucose and glutamine into de novo nucleotide biosynthesis Cancer & Metabolism. 2: O10. DOI: 10.1186/2049-3002-2-S1-O10  0.389
2014 Dang CV. Oncogenic alterations of metabolism Aacr Education Book. 2014: 3-6. DOI: 10.1158/Aacr.Edb-14-7938  0.378
2014 Stine Z, Xiang Y, Xia J, Gao P, Dinavahi R, Dang CV. Abstract 2957: Inhibition of glutaminase induces slows tumor growth cell autonomously and promotes survival in a MYC driven hepatocellular carcinoma mouse model Cancer Research. 74: 2957-2957. DOI: 10.1158/1538-7445.Am2014-2957  0.46
2014 Altman BJ, Hsieh A, Gouw AM, Stine ZE, Venkataraman A, Bellovin DI, Diskin SJ, Lu W, Zhang S, Felsher DW, Maris JM, Lazar MA, Rabinowitz JD, Hogenesch JB, Dang CV. Abstract 2953: Rev-erbα modulates Myc-driven cancer cell growth and altered metabolism Cancer Research. 74: 2953-2953. DOI: 10.1158/1538-7445.Am2014-2953  0.536
2014 Hsieh AL, Altman BJ, Venkataraman A, Bellovin DI, Felsher DW, Hogenesch JB, Dang CV. Abstract 1419: Oncogenic Myc disrupts NAMPT circadian oscillation in mouse hepatocellular carcinoma cell line Cancer Research. 74: 1419-1419. DOI: 10.1158/1538-7445.Am2014-1419  0.513
2013 Stine ZE, Dang CV. Stress eating and tuning out: Cancer cells re-wire metabolism to counter stress Critical Reviews in Biochemistry and Molecular Biology. 48: 609-619. PMID 24099138 DOI: 10.3109/10409238.2013.844093  0.478
2013 Le A, Dang CV. Studying Myc's role in metabolism regulation. Methods in Molecular Biology (Clifton, N.J.). 1012: 213-9. PMID 24006067 DOI: 10.1007/978-1-62703-429-6_14  0.481
2013 Dang CV. MYC, metabolism, cell growth, and tumorigenesis. Cold Spring Harbor Perspectives in Medicine. 3. PMID 23906881 DOI: 10.1101/Cshperspect.A014217  0.556
2013 Dutta P, Le A, Vander Jagt DL, Tsukamoto T, Martinez GV, Dang CV, Gillies RJ. Evaluation of LDH-A and glutaminase inhibition in vivo by hyperpolarized 13C-pyruvate magnetic resonance spectroscopy of tumors. Cancer Research. 73: 4190-5. PMID 23722553 DOI: 10.1158/0008-5472.Can-13-0465  0.369
2013 Wu G, Yustein JT, McCall MN, Zilliox M, Irizarry RA, Zeller K, Dang CV, Ji H. ChIP-PED enhances the analysis of ChIP-seq and ChIP-chip data. Bioinformatics (Oxford, England). 29: 1182-1189. PMID 23457041 DOI: 10.1093/Bioinformatics/Btt108  0.315
2013 Hubbi ME, Kshitiz, Gilkes DM, Rey S, Wong CC, Luo W, Kim DH, Dang CV, Levchenko A, Semenza GL. A nontranscriptional role for HIF-1α as a direct inhibitor of DNA replication Science Signaling. 6. PMID 23405012 DOI: 10.1126/Scisignal.2003417  0.353
2013 Dang CV. Role of aerobic glycolysis in genetically engineered mouse models of cancer Bmc Biology. 11. PMID 23342984 DOI: 10.1186/1741-7007-11-3  0.447
2013 Eisenman RN, Dang CV. Unlocking the mysterious mechanisms of myc Nature Medicine. 19: 26-27. PMID 23296005 DOI: 10.1038/Nm.3060  0.3
2013 Murphy TA, Dang CV, Young JD. Isotopically nonstationary 13C flux analysis of Myc-induced metabolic reprogramming in B-cells Metabolic Engineering. 15: 206-217. PMID 22898717 DOI: 10.1016/J.Ymben.2012.07.008  0.355
2013 Poore B, Park JK, Afif I, Shingleton L, Dang CV, Le A. Abstract 852: Novel role and mechanism of the LDHA protein as a survival factor for cancer cells. Cancer Research. 73: 852-852. DOI: 10.1158/1538-7445.Am2013-852  0.438
2013 Rajeshkumar NV, Yabuuchi S, Patel C, Pai SG, Le DT, Hoff DDV, Dang CV, Maitra A, Powell J. Abstract 5396: Targeting multiple components of the mammalian target of rapamycin (mTOR) signaling: A novel combination therapy to improve pancreatic cancer treatment. Cancer Research. 73: 5396-5396. DOI: 10.1158/1538-7445.Am2013-5396  0.419
2013 Altman BJ, Hsieh A, Gouw A, Venkataraman A, Li B, Bellovin D, Simon MC, Felsher D, Hogenesch J, Dang CV. Abstract 4616: Oncogenic c- and N-Myc disrupt circadian rhythm. Cancer Research. 73: 4616-4616. DOI: 10.1158/1538-7445.Am2013-4616  0.684
2013 Gouw AM, Mancuso A, Hsieh AL, Altman B, Wolfgang M, Dang CV. Abstract 1879: Myc induces lipogenesis and suppresses fatty acid oxidation in human P493-6 B-lymphoma cells. Cancer Research. 73: 1879-1879. DOI: 10.1158/1538-7445.Am2013-1879  0.78
2013 Dang CV. MYC, metabolism, cell growth, and tumorigenesis Cold Spring Harbor Perspectives in Biology. 5. DOI: 10.1101/cshperspect.a014217  0.317
2012 Shukla K, Ferraris DV, Thomas AG, Stathis M, Duvall B, Delahanty G, Alt J, Rais R, Rojas C, Gao P, Xiang Y, Dang CV, Slusher BS, Tsukamoto T. Design, synthesis, and pharmacological evaluation of bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl)ethyl sulfide 3 (BPTES) analogs as glutaminase inhibitors. Journal of Medicinal Chemistry. 55: 10551-63. PMID 23151085 DOI: 10.1021/Jm301191P  0.302
2012 Le A, Rajeshkumar NV, Maitra A, Dang CV. Conceptual framework for cutting the pancreatic cancer fuel supply. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 4285-90. PMID 22896695 DOI: 10.1158/1078-0432.Ccr-12-0041  0.393
2012 Altman BJ, Dang CV. Normal and cancer cell metabolism: Lymphocytes and lymphoma Febs Journal. 279: 2598-2609. PMID 22672505 DOI: 10.1111/J.1742-4658.2012.08651.X  0.481
2012 Liu W, Le A, Hancock C, Lane AN, Dang CV, Fan TW, Phang JM. Reprogramming of proline and glutamine metabolism contributes to the proliferative and metabolic responses regulated by oncogenic transcription factor c-MYC. Proceedings of the National Academy of Sciences of the United States of America. 109: 8983-8. PMID 22615405 DOI: 10.1073/Pnas.1203244109  0.498
2012 Dang CV. Cancer cell metabolism: There is no ROS for the weary Cancer Discovery. 2: 304-307. PMID 22576206 DOI: 10.1158/2159-8290.Cd-12-0069  0.432
2012 Dang CV. Links between metabolism and cancer Genes and Development. 26: 877-890. PMID 22549953 DOI: 10.1101/Gad.189365.112  0.479
2012 Dang CV. MYC on the path to cancer Cell. 149: 22-35. PMID 22464321 DOI: 10.1016/J.Cell.2012.03.003  0.529
2012 Le A, Lane AN, Hamaker M, Bose S, Gouw A, Barbi J, Tsukamoto T, Rojas CJ, Slusher BS, Zhang H, Zimmerman LJ, Liebler DC, Slebos RJ, Lorkiewicz PK, Higashi RM, ... ... Dang CV, et al. Glucose-independent glutamine metabolism via TCA cycling for proliferation and survival in B cells. Cell Metabolism. 15: 110-21. PMID 22225880 DOI: 10.1016/J.Cmet.2011.12.009  0.661
2012 Fan J, Chen YC, Watkins T, Dang CV, Gorospe M, Cheadle C. Array-based nuclear run-on analysis Methods in Molecular Biology. 809: 505-517. PMID 22113297 DOI: 10.1007/978-1-61779-376-9_33  0.332
2012 Rajeshkumar NV, Dutta P, Kamphorst J, Le A, Yabuuchi S, Wilde RFd, Campbell NR, Oliveira ED, Jesus-Acosta AD, Rabinowitz J, Laheru D, Jain SK, Hidalgo M, Thompson CB, Hoff DDV, ... ... Dang CV, et al. Abstract LB-61: Targeting cancer cell metabolism in pancreatic cancer: p53, a key regulator of glycolysis and a major factor deciding the outcome of targeting the Warburg effect Cancer Research. 72. DOI: 10.1158/1538-7445.Am2012-Lb-61  0.488
2012 Gouw AM, Hsieh AL, Le A, Maitra A, Dang CV. Abstract 5242: Pancreatic cancer cell type specific oxygen dependent growth and drug sensitivity Cancer Research. 72: 5242-5242. DOI: 10.1158/1538-7445.Am2012-5242  0.726
2011 Ji H, Wu G, Zhan X, Nolan A, Koh C, de Marzo A, Doan HM, Fan J, Cheadle C, Fallahi M, Cleveland JL, Dang CV, Zeller KI. Cell-type independent MYC target genes reveal a primordial signature involved in biomass accumulation Plos One. 6. PMID 22039435 DOI: 10.1371/Journal.Pone.0026057  0.504
2011 Emadi A, Le A, Harwood CJ, Stagliano KW, Kamangar F, Ross AE, Cooper CR, Dang CV, Karp JE, Vuica-Ross M. Metabolic and electrochemical mechanisms of dimeric naphthoquinones cytotoxicity in breast cancer cells. Bioorganic & Medicinal Chemistry. 19: 7057-62. PMID 22036210 DOI: 10.1016/J.Bmc.2011.10.005  0.412
2011 Dang CV. Therapeutic targeting of Myc-reprogrammed cancer cell metabolism Cold Spring Harbor Symposia On Quantitative Biology. 76: 369-374. PMID 21960526 DOI: 10.1101/Sqb.2011.76.011296  0.545
2011 Koppenol WH, Bounds PL, Dang CV. Otto Warburg's contributions to current concepts of cancer metabolism Nature Reviews Cancer. 11: 325-337. PMID 21508971 DOI: 10.1038/Nrc3038  0.45
2011 Koh CM, Gurel B, Sutcliffe S, Aryee MJ, Schultz D, Iwata T, Uemura M, Zeller KI, Anele U, Zheng Q, Hicks JL, Nelson WG, Dang CV, Yegnasubramanian S, De Marzo AM. Alterations in nucleolar structure and gene expression programs in prostatic neoplasia are driven by the MYC oncogene. The American Journal of Pathology. 178: 1824-34. PMID 21435462 DOI: 10.1016/J.Ajpath.2010.12.040  0.346
2011 Dang CV, Hamaker M, Sun P, Le A, Gao P. Therapeutic targeting of cancer cell metabolism. Journal of Molecular Medicine (Berlin, Germany). 89: 205-12. PMID 21301795 DOI: 10.1007/S00109-011-0730-X  0.489
2011 Ji H, Wu G, Zhan X, Nolan A, Koh C, Marzo AD, Fan J, Cheadle C, Fallahi M, Cleveland J, Dang CV, Zeller K. Abstract 928: Species and cell type independent core MYC target genes in cancer and stem cells Cancer Research. 71: 928-928. DOI: 10.1158/1538-7445.Am2011-928  0.492
2011 Le A, Hamaker M, Zhang H, Zimmerman LJ, Dinavahi R, Gao P, Liebler DC, Slebos RJC, Moseley H, Higashi RM, Lane A, Fan TWM, Dang CV. Abstract 2799: Unexpected sustained hypoxic glutamine metabolism and therapeutic opportunities Cancer Research. 71: 2799-2799. DOI: 10.1158/1538-7445.Am2011-2799  0.497
2011 Koppenol WH, Bounds PL, Dang CV. Erratum: Otto Warburg's contributions to current concepts of cancer metabolism Nature Reviews Cancer. 11: 618-618. DOI: 10.1038/Nrc3108  0.367
2010 Koh CM, Bieberich CJ, Dang CV, Nelson WG, Yegnasubramanian S, De Marzo AM. MYC and Prostate Cancer. Genes & Cancer. 1: 617-28. PMID 21779461 DOI: 10.1177/1947601910379132  0.375
2010 Dang CV. Enigmatic MYC Conducts an Unfolding Systems Biology Symphony. Genes & Cancer. 1: 526-531. PMID 21218193 DOI: 10.1177/1947601910378742  0.48
2010 Seltzer MJ, Bennett BD, Joshi AD, Gao P, Thomas AG, Ferraris DV, Tsukamoto T, Rojas CJ, Slusher BS, Rabinowitz JD, Dang CV, Riggins GJ. Inhibition of glutaminase preferentially slows growth of glioma cells with mutant IDH1. Cancer Research. 70: 8981-7. PMID 21045145 DOI: 10.1158/0008-5472.Can-10-1666  0.385
2010 Dang CV. Glutaminolysis: Supplying carbon or nitrogen or both for cancer cells? Cell Cycle. 9: 3884-3886. PMID 20948290 DOI: 10.4161/Cc.9.19.13302  0.451
2010 Wang JB, Erickson JW, Fuji R, Ramachandran S, Gao P, Dinavahi R, Wilson KF, Ambrosio AL, Dias SM, Dang CV, Cerione RA. Targeting mitochondrial glutaminase activity inhibits oncogenic transformation. Cancer Cell. 18: 207-19. PMID 20832749 DOI: 10.1016/J.Ccr.2010.08.009  0.425
2010 Fan JS, Zeller K, Chen YC, Watkins T, Barnes KC, Becker KG, Dang CV, Cheadle C. Time-dependent c-Myc transactomes mapped by array-based nuclear run-on reveal transcriptional modules in human B cells Plos One. 5. PMID 20300622 DOI: 10.1371/Journal.Pone.0009691  0.402
2010 Iwata T, Schultz D, Hicks J, Hubbard GK, Mutton LN, Lotan TL, Bethel C, Lotz MT, Yegnasubramanian S, Nelson WG, Dang CV, Xu M, Anele U, Koh CM, Bieberich CJ, et al. MYC overexpression induces prostatic intraepithelial neoplasia and loss of Nkx3.1 in mouse luminal epithelial cells. Plos One. 5: e9427. PMID 20195545 DOI: 10.1371/Journal.Pone.0009427  0.383
2010 Le A, Cooper CR, Gouw AM, Dinavahi R, Maitra A, Deck LM, Royer RE, Vander Jagt DL, Semenza GL, Dang CV. Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression. Proceedings of the National Academy of Sciences of the United States of America. 107: 2037-42. PMID 20133848 DOI: 10.1073/Pnas.0914433107  0.685
2010 Yustein JT, Liu YC, Gao P, Jie C, Le A, Vuica-Ross M, Chng WJ, Eberhart CG, Bergsagel PL, Dang CV. Induction of ectopic Myc target gene JAG2 augments hypoxic growth and tumorigenesis in a human B-cell model. Proceedings of the National Academy of Sciences of the United States of America. 107: 3534-9. PMID 20133585 DOI: 10.1073/Pnas.0901230107  0.462
2010 Dang CV. p32 (C1QBP) and cancer cell metabolism: Is the Warburg effect a lot of hot air? Molecular and Cellular Biology. 30: 1300-1302. PMID 20100868 DOI: 10.1128/Mcb.01661-09  0.45
2010 Dang CV. Rethinking the warburg effect with Myc micromanaging glutamine metabolism Cancer Research. 70: 859-862. PMID 20086171 DOI: 10.1158/0008-5472.Can-09-3556  0.481
2010 Le A, Cooper CR, Gouw A, Maitra A, Dinavahi R, Deck L, Royer R, Jagt DV, Semenza G, Dang CV. Abstract 5453: Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression Cancer Research. 70: 5453-5453. DOI: 10.1158/1538-7445.Am10-5453  0.684
2010 Ricklis RM, Vuica-Ross M, Brodsky RA, Sausville E, Dang CV, Karp JE, Emadi A. Abstract 4539: Anti-leukemic activity of mitochondria-targeted asymmetrical 2,2′-binaphthoquinones Cancer Research. 70: 4539-4539. DOI: 10.1158/1538-7445.Am10-4539  0.372
2009 Dang CV. PKM2 tyrosine phosphorylation and glutamine metabolism signal a different view of the warburg effect Science Signaling. 2: pe75. PMID 19920249 DOI: 10.1126/Scisignal.297Pe75  0.388
2009 Dang CV. Edging toward New Therapeutics with Cyclin D1 Egl'ng on Cancer Cancer Cell. 16: 361-362. PMID 19878865 DOI: 10.1016/J.Ccr.2009.10.001  0.362
2009 Dang CV, Le A, Gao P. MYC-induced cancer cell energy metabolism and therapeutic opportunities. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 6479-83. PMID 19861459 DOI: 10.1158/1078-0432.Ccr-09-0889  0.552
2009 Dang CV. Micro-managing and restraining pluripotent stem cells by MYC Embo Journal. 28: 3065-3066. PMID 19844252 DOI: 10.1038/Emboj.2009.293  0.406
2009 Dang CV. MYC, microRNAs and glutamine addiction in cancers Cell Cycle. 8: 3243-3245. PMID 19806017 DOI: 10.4161/Cc.8.20.9522  0.492
2009 Ye Z, Zhan H, Mali P, Dowey S, Williams DM, Jang YY, Dang CV, Spivak JL, Moliterno AR, Cheng L. Human-induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders Blood. 114: 5473-5480. PMID 19797525 DOI: 10.1182/Blood-2009-04-217406  0.328
2009 Flögel U, Dang CV. Myoglobin tames tumor growth and spread Journal of Clinical Investigation. 119: 766-768. PMID 19348046 DOI: 10.1172/Jci38796  0.333
2009 Gao P, Tchernyshyov I, Chang TC, Lee YS, Kita K, Ochi T, Zeller KI, De Marzo AM, Van Eyk JE, Mendell JT, Dang CV. C-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism Nature. 458: 762-765. PMID 19219026 DOI: 10.1038/Nature07823  0.491
2009 Chang TC, Zeitels LR, Hwang HW, Chivukula RR, Wentzel EA, Dews M, Jung J, Gao P, Dang CV, Beer MA, Thomas-Tikhonenko A, Mendella JT. Lin-28B transactivation is necessary for Myc-mediated let-7 repression and proliferation Proceedings of the National Academy of Sciences of the United States of America. 106: 3384-3389. PMID 19211792 DOI: 10.1073/Pnas.0808300106  0.633
2009 Ricklis R, Vuica-Ross M, Brodsky R, Sausville E, Dang CV, Karp JE, Emadi A. Anti-Leukemic Activity of Mitochondrially-Directed Asymmetrical 2-2'-Binaphthoquinones. Blood. 114: 4799-4799. DOI: 10.1182/Blood.V114.22.4799.4799  0.356
2008 Zhang H, Qian DZ, Tan YS, Lee K, Gao P, Ren YR, Rey S, Hammers H, Chang D, Pili R, Dang CV, Liu JO, Semenza GL. Digoxin and other cardiac glycosides inhibit HIF-1α synthesis and block tumor growth Proceedings of the National Academy of Sciences of the United States of America. 105: 19579-19586. PMID 19020076 DOI: 10.1073/Pnas.0809763105  0.409
2008 Liu YC, Li F, Handler J, Huang CR, Xiang Y, Neretti N, Sedivy JM, Zeller KI, Dang CV. Global regulation of nucleotide biosynthetic genes by c-Myc. Plos One. 3: e2722. PMID 18628958 DOI: 10.1371/Journal.Pone.0002722  0.498
2008 Dang CV. Antimalarial therapy prevents Myc-induced lymphoma Journal of Clinical Investigation. 118: 15-17. PMID 18097478 DOI: 10.1172/Jci34503  0.369
2008 Chang TC, Yu D, Lee YS, Wentzel EA, Arking DE, West KM, Dang CV, Thomas-Tikhonenko A, Mendell JT. Widespread microRNA repression by Myc contributes to tumorigenesis Nature Genetics. 40: 43-50. PMID 18066065 DOI: 10.1038/Ng.2007.30  0.608
2008 Dang CV, Kim JW, Gao P, Yustein J. The interplay between MYC and HIF in cancer Nature Reviews Cancer. 8: 51-56. PMID 18046334 DOI: 10.1038/Nrc2274  0.404
2007 Dang CV. The interplay between MYC and HIF in the Warburg effect. Ernst Schering Foundation Symposium Proceedings. 35-53. PMID 18811052  0.431
2007 Kim JW, Gao P, Liu YC, Semenza GL, Dang CV. Hypoxia-inducible factor 1 and dysregulated c-Myc cooperatively induce vascular endothelial growth factor and metabolic switches hexokinase 2 and pyruvate dehydrogenase kinase 1 Molecular and Cellular Biology. 27: 7381-7393. PMID 17785433 DOI: 10.1128/Mcb.00440-07  0.464
2007 Gao P, Zhang H, Dinavahi R, Li F, Xiang Y, Raman V, Bhujwalla ZM, Felsher DW, Cheng L, Pevsner J, Lee LA, Semenza GL, Dang CV. HIF-dependent antitumorigenic effect of antioxidants in vivo. Cancer Cell. 12: 230-8. PMID 17785204 DOI: 10.1016/J.Ccr.2007.08.004  0.326
2007 Zhang H, Gao P, Fukuda R, Kumar G, Krishnamachary B, Zeller KI, Dang CV, Semenza GL. HIF-1 inhibits mitochondrial biogenesis and cellular respiration in VHL-deficient renal cell carcinoma by repression of C-MYC activity. Cancer Cell. 11: 407-20. PMID 17482131 DOI: 10.1016/J.Ccr.2007.04.001  0.348
2007 Fukuda R, Zhang H, Kim Jw, Shimoda L, Dang CV, Semenza G. HIF-1 Regulates Cytochrome Oxidase Subunits to Optimize Efficiency of Respiration in Hypoxic Cells Cell. 129: 111-122. PMID 17418790 DOI: 10.1016/J.Cell.2007.01.047  0.344
2007 Kim JW, Gao P, Dang CV. Effects of hypoxia on tumor metabolism Cancer and Metastasis Reviews. 26: 291-298. PMID 17415528 DOI: 10.1007/S10555-007-9060-4  0.401
2006 Zeller KI, Zhao X, Lee CWH, Kuo PC, Yao F, Yustein JT, Hong SO, Orlov YL, Shahab A, How CY, Fu Y, Weng Z, Kuznetsov VA, Sung WK, Ruan Y, ... Dang CV, et al. Global mapping of c-Myc binding sites and target gene networks in human B cells Proceedings of the National Academy of Sciences of the United States of America. 103: 17834-17839. PMID 17093053 DOI: 10.1073/Pnas.0604129103  0.471
2006 Kim JW, Dang CV. Cancer's molecular sweet tooth and the warburg effect Cancer Research. 66: 8927-8930. PMID 16982728 DOI: 10.1158/0008-5472.Can-06-1501  0.417
2006 Dang CV, O'Donnell KA, Zeller KI, Nguyen T, Osthus RC, Li F. The c-Myc target gene network Seminars in Cancer Biology. 16: 253-264. PMID 16904903 DOI: 10.1016/J.Semcancer.2006.07.014  0.432
2006 Deb-Basu D, Karlsson A, Li Q, Dang CV, Felsher DW. MYC can enforce cell cycle transit from G1 to S and G 2 to S, but not mitotic cellular division, independent of p27-mediated inihibition of cyclin E/CDK2 Cell Cycle. 5: 1348-1355. PMID 16760657 DOI: 10.4161/Cc.5.12.2860  0.371
2006 Li F, Xiang Y, Potter J, Dinavahi R, Dang CV, Lee LA. Conditional deletion of c-myc does not impair liver regeneration Cancer Research. 66: 5608-5612. PMID 16740696 DOI: 10.1158/0008-5472.Can-05-4242  0.308
2006 Lee LA, Dang CV. Myc target transcriptomes Current Topics in Microbiology and Immunology. 302: 145-167. PMID 16620028 DOI: 10.1007/3-540-32952-8_6  0.435
2006 Kim JW, Tchernyshyov I, Semenza GL, Dang CV. HIF-1-mediated expression of pyruvate dehydrogenase kinase: A metabolic switch required for cellular adaptation to hypoxia Cell Metabolism. 3: 177-185. PMID 16517405 DOI: 10.1016/J.Cmet.2006.02.002  0.423
2006 O'Donnell KA, Yu D, Zeller KI, Kim JW, Racke F, Thomas-Tikhonenko A, Dang CV. Activation of transferrin receptor 1 by c-Myc enhances cellular proliferation and tumorigenesis Molecular and Cellular Biology. 26: 2373-2386. PMID 16508012 DOI: 10.1128/Mcb.26.6.2373-2386.2006  0.713
2006 Stearns D, Chaudhry A, Abel TW, Burger PC, Dang CV, Eberhart CG. c-myc overexpression causes anaplasia in medulloblastoma. Cancer Research. 66: 673-81. PMID 16423996 DOI: 10.1158/0008-5472.Can-05-1580  0.418
2005 Dang CV, O'donnell KA, Juopperi T. The great MYC escape in tumorigenesis. Cancer Cell. 8: 177-8. PMID 16169462 DOI: 10.1016/J.Ccr.2005.08.005  0.372
2005 Osthus RC, Karim B, Prescott JE, Smith BD, McDevitt M, Huso DL, Dang CV. The Myc target gene JPO1/CDCA7 is frequently overexpressed in human tumors and has limited transforming activity in vivo. Cancer Research. 65: 5620-7. PMID 15994934 DOI: 10.1158/0008-5472.Can-05-0536  0.453
2005 Li F, Wang Y, Zeller KI, Potter JJ, Wonsey DR, O'Donnell KA, Kim JW, Yustein JT, Lee LA, Dang CV. Myc stimulates nuclearly encoded mitochondrial genes and mitochondrial biogenesis. Molecular and Cellular Biology. 25: 6225-34. PMID 15988031 DOI: 10.1128/Mcb.25.14.6225-6234.2005  0.361
2005 O'Donnell KA, Wentzel EA, Zeller KI, Dang CV, Mendell JT. c-Myc-regulated microRNAs modulate E2F1 expression. Nature. 435: 839-43. PMID 15944709 DOI: 10.1038/Nature03677  0.381
2005 Barrett JF, Lee LA, Dang CV. Stimulation of Myc transactivation by the TATA binding protein in promoter-reporter assays. Bmc Biochemistry. 6: 7. PMID 15876353 DOI: 10.1186/1471-2091-6-7  0.396
2005 Chou WC, Chen HY, Yu SL, Cheng L, Yang PC, Dang CV. Arsenic suppresses gene expression in promyelocytic leukemia cells partly through Sp1 oxidation. Blood. 106: 304-10. PMID 15761015 DOI: 10.1182/Blood-2005-01-0241  0.367
2005 Kim JW, Dang CV. Multifaceted roles of glycolytic enzymes. Trends in Biochemical Sciences. 30: 142-50. PMID 15752986 DOI: 10.1016/J.Tibs.2005.01.005  0.369
2005 Chou WC, Dang CV. Acute promyelocytic leukemia: recent advances in therapy and molecular basis of response to arsenic therapies. Current Opinion in Hematology. 12: 1-6. PMID 15604884 DOI: 10.1097/01.Moh.0000148552.93303.45  0.313
2005 Dang CV, Semenza GL. Cancer energy metabolism Drug Discovery Today: Disease Mechanisms. 2. DOI: 10.1016/J.Ddmec.2005.05.039  0.385
2005 Kim JW, Gardner LB, Dang CV. Oncogenic alterations of metabolism and the Warburg effect Drug Discovery Today: Disease Mechanisms. 2: 233-238. DOI: 10.1016/J.Ddmec.2005.04.001  0.449
2004 Perry ME, Dang CV, Hockenbery D, Moll U. Highlights of the National Cancer Institute Workshop on mitochondrial function and cancer. Cancer Research. 64: 7640-4. PMID 15492294 DOI: 10.1158/0008-5472.Can-04-1991  0.365
2004 Elkon R, Zeller KI, Linhart C, Dang CV, Shamir R, Shiloh Y. In silico identification of transcriptional regulators associated with c-Myc. Nucleic Acids Research. 32: 4955-61. PMID 15388797 DOI: 10.1093/Nar/Gkh816  0.406
2004 Kim JW, Zeller KI, Wang Y, Jegga AG, Aronow BJ, O'Donnell KA, Dang CV. Evaluation of myc E-box phylogenetic footprints in glycolytic genes by chromatin immunoprecipitation assays. Molecular and Cellular Biology. 24: 5923-36. PMID 15199147 DOI: 10.1128/Mcb.24.13.5923-5936.2004  0.389
2004 Eberhart CG, Kratz J, Wang Y, Summers K, Stearns D, Cohen K, Dang CV, Burger PC. Histopathological and molecular prognostic markers in medulloblastoma: c-myc, N-myc, TrkC, and anaplasia. Journal of Neuropathology and Experimental Neurology. 63: 441-9. PMID 15198123 DOI: 10.1093/Jnen/63.5.441  0.365
2004 Chou WC, Jie C, Kenedy AA, Jones RJ, Trush MA, Dang CV. Role of NADPH oxidase in arsenic-induced reactive oxygen species formation and cytotoxicity in myeloid leukemia cells. Proceedings of the National Academy of Sciences of the United States of America. 101: 4578-83. PMID 15070760 DOI: 10.1073/Pnas.0306687101  0.394
2004 Takemoto CM, Shahlaee AH, Ye Y, Zeller KI, Zablocki D, Huynh J, Huang S, DeKoter RP, Jegga AG, Aronow BJ, Dang CV, McDevitt MA. Transcriptional Regulation of a Distinct GATA-1 Isoform during Selection of the Mast and Erythroid Lineages. Blood. 104: 1600-1600. DOI: 10.1182/Blood.V104.11.1600.1600  0.389
2003 Gardner LB, Li F, Yang X, Dang CV. Anoxic fibroblasts activate a replication checkpoint that is bypassed by E1a. Molecular and Cellular Biology. 23: 9032-45. PMID 14645516 DOI: 10.1128/Mcb.23.24.9032-9045.2003  0.41
2003 Ulanet DB, Torbenson M, Dang CV, Casciola-Rosen L, Rosen A. Unique conformation of cancer autoantigen B23 in hepatoma: a mechanism for specificity in the autoimmune response. Proceedings of the National Academy of Sciences of the United States of America. 100: 12361-6. PMID 14519847 DOI: 10.1073/Pnas.2035245100  0.315
2003 Zeller KI, Jegga AG, Aronow BJ, O'Donnell KA, Dang CV. An integrated database of genes responsive to the Myc oncogenic transcription factor: identification of direct genomic targets. Genome Biology. 4: R69. PMID 14519204 DOI: 10.1186/Gb-2003-4-10-R69  0.376
2003 Fan X, Wang Y, Kratz J, Brat DJ, Robitaille Y, Moghrabi A, Perlman EJ, Dang CV, Burger PC, Eberhart CG. hTERT gene amplification and increased mRNA expression in central nervous system embryonal tumors. The American Journal of Pathology. 162: 1763-9. PMID 12759234 DOI: 10.1016/S0002-9440(10)64311-8  0.33
2003 Haggerty TJ, Zeller KI, Osthus RC, Wonsey DR, Dang CV. A strategy for identifying transcription factor binding sites reveals two classes of genomic c-Myc target sites. Proceedings of the National Academy of Sciences of the United States of America. 100: 5313-8. PMID 12702757 DOI: 10.1073/Pnas.0931346100  0.334
2003 Johnson SA, Dubeau L, Kawalek M, Dervan A, Schönthal AH, Dang CV, Johnson DL. Increased expression of TATA-binding protein, the central transcription factor, can contribute to oncogenesis. Molecular and Cellular Biology. 23: 3043-51. PMID 12697807 DOI: 10.1128/Mcb.23.9.3043-3051.2003  0.6
2003 Kenedy AA, Cohen KJ, Loveys DA, Kato GJ, Dang CV. Identification and characterization of the novel centrosome-associated protein CCCAP Gene. 303: 35-46. PMID 12559564 DOI: 10.1016/S0378-1119(02)01141-1  0.369
2002 Small GW, Chou TY, Dang CV, Orlowski RZ. Evidence for involvement of calpain in c-Myc proteolysis in vivo. Archives of Biochemistry and Biophysics. 400: 151-61. PMID 12054425 DOI: 10.1016/S0003-9861(02)00005-X  0.367
2002 Wonsey DR, Zeller KI, Dang CV. The c-Myc target gene PRDX3 is required for mitochondrial homeostasis and neoplastic transformation Proceedings of the National Academy of Sciences of the United States of America. 99: 6649-6654. PMID 12011429 DOI: 10.1073/Pnas.102523299  0.438
2001 Chou WC, Hawkins AL, Barrett JF, Griffin CA, Dang CV. Arsenic inhibition of telomerase transcription leads to genetic instability Journal of Clinical Investigation. 108: 1541-1547. PMID 11714746 DOI: 10.1172/Jci14064  0.385
2001 Boxer LM, Dang CV. Translocations involving c-myc and c-myc function Oncogene. 20: 5595-5610. PMID 11607812 DOI: 10.1038/Sj.Onc.1204595  0.46
2001 Zeller KI, Haggerty TJ, Barrett JF, Guo Q, Wonsey DR, Dang CV. Characterization of Nucleophosmin (B23) as a Myc Target by Scanning Chromatin Immunoprecipitation Journal of Biological Chemistry. 276: 48285-48291. PMID 11604407 DOI: 10.1074/Jbc.M108506200  0.376
2001 Prescott JE, Osthus RC, Lee LA, Lewis BC, Shim H, Barrett JF, Guo Q, Hawkins AL, Griffin CA, Dang CV. A Novel c-Myc-responsive Gene, JP01, Participates in Neoplastic Transformation Journal of Biological Chemistry. 276: 48276-48284. PMID 11598121 DOI: 10.1074/Jbc.M107357200  0.399
2001 Kuttler F, Amé P, Clark H, Haughey C, Mougin C, Cahn JY, Dang CV, Raffeld M, Fest T. c-myc box II mutations in Burkitt's lymphoma-derived alleles reduce cell-transformation activity and lower response to broad apoptotic stimuli Oncogene. 20: 6084-6094. PMID 11593416 DOI: 10.1038/Sj.Onc.1204827  0.36
2001 Kim S, Zeller K, Dang CV, Sandgren EP, Lee LA. A strategy to identify differentially expressed genes using representational difference analysis and cDNA arrays Analytical Biochemistry. 288: 141-148. PMID 11152584 DOI: 10.1006/Abio.2000.4900  0.339
2001 Gardner LB, Li Q, Park MS, Flanagan WM, Semenza GL, Dang CV. Hypoxia Inhibits G1/S Transition through Regulation of p27 Expression Journal of Biological Chemistry. 276: 7919-7926. PMID 11112789 DOI: 10.1074/Jbc.M010189200  0.376
2000 Lewis BC, Prescott JE, Campbell SE, Shim H, Orlowski RZ, Dang CV. Tumor induction by the c-Myc target genes rcl and lactate dehydrogenase A. Cancer Research. 60: 6178-83. PMID 11085542  0.343
2000 Kim S, Li Q, Dang CV, Lee LA. Induction of ribosomal genes and hepatocyte hypertrophy by adenovirus-mediated expression of c-Myc in vivo Proceedings of the National Academy of Sciences of the United States of America. 97: 11198-11202. PMID 11005843 DOI: 10.1073/Pnas.200372597  0.432
2000 Osthus RC, Shim H, Kim S, Li Q, Reddy R, Mukherjee M, Xu Y, Wonsey D, Lee LA, Dang CV. Deregulation of glucose transporter 1 and glycolytic gene expression by c-Myc Journal of Biological Chemistry. 275: 21797-21800. PMID 10823814 DOI: 10.1074/Jbc.C000023200  0.437
2000 Hermeking H, Rago C, Schuhmacher M, Li Q, Barrett JF, Obaya AJ, O'Connell BC, Mateyak MK, Tam W, Kohlhuber F, Dang CV, Sedivy JM, Eick D, Vogelstein B, Kinzler KW. Identification of CDK4 as a target of c-MYC. Proceedings of the National Academy of Sciences of the United States of America. 97: 2229-34. PMID 10688915 DOI: 10.1073/Pnas.050586197  0.441
2000 Barr LF, Campbell SE, Diette GB, Gabrielson EW, Kim S, Shim H, Dang CV. c-Myc suppresses the tumorigenicity of lung cancer cells and down-regulates vascular endothelial growth factor expression. Cancer Research. 60: 143-9. PMID 10646866  0.34
2000 Kim S, Zeller K, Li Q, Dang CV, Lee LA. Induction of ribosomal genes and a novel phenotype of hepatocyte hypertrophy by adenovirus-mediated expression of C-MYC in vivo Gastroenterology. 118: A1020. DOI: 10.1016/S0016-5085(00)86233-2  0.386
1999 Dang CV, Resar LMS, Emison E, Kim S, Li Q, Prescott JE, Wonsey D, Zeller K. Function of the c-Myc oncogenic transcription factor Experimental Cell Research. 253: 63-77. PMID 10579912 DOI: 10.1006/Excr.1999.4686  0.453
1999 Kolligs FT, Hu G, Dang CV, Fearon ER. Neoplastic transformation of RK3E by mutant β-catenin requires deregulation of Tcf/Lef transcription but not activation of c-myc expression Molecular and Cellular Biology. 19: 5696-5706. PMID 10409758 DOI: 10.1128/Mcb.19.8.5696  0.309
1999 Li Q, Dang CV. c-myc overexpression uncouples DNA replication from mitosis Molecular and Cellular Biology. 19: 5339-5351. PMID 10409725 DOI: 10.1128/Mcb.19.8.5339  0.422
1999 Dang CV, Semenza GL. Oncogenic alterations of metabolism Trends in Biochemical Sciences. 24: 68-72. PMID 10098401 DOI: 10.1016/S0968-0004(98)01344-9  0.454
1999 Fearon ER, Dang CV. Cancer genetics: Tumor suppressor meets oncogene Current Biology. 9: R62-R65. PMID 10021355 DOI: 10.1016/S0960-9822(99)80012-8  0.427
1999 Dang CV. c-Myc target genes involved in cell growth, apoptosis, and metabolism Molecular and Cellular Biology. 19: 1-11. PMID 9858526 DOI: 10.1128/Mcb.19.1.1  0.464
1998 Barr LF, Campbell SE, Bochner BS, Dang CV. Association of the decreased expression of α3β1 integrin with the altered cell: Environmental interactions and enhanced soft agar cloning ability of c-myc-overexpressing small cell lung cancer cells Cancer Research. 58: 5537-5545. PMID 9850091  0.324
1998 Guo Q, Xie J, Dang CV, Liu ET, Bishop JM. Identification of a large Myc-binding protein that contains RCC1-like repeats. Proceedings of the National Academy of Sciences of the United States of America. 95: 9172-7. PMID 9689053 DOI: 10.1073/Pnas.95.16.9172  0.647
1998 Shim H, Chun YS, Lewis BC, Dang CV. A unique glucose-dependent apoptotic pathway induced by c-Myc Proceedings of the National Academy of Sciences of the United States of America. 95: 1511-1516. PMID 9465046 DOI: 10.1073/Pnas.95.4.1511  0.437
1997 Pangilinan F, Li Q, Weaver T, Lewis BC, Dang CV, Spencer F. Mammalian BUB1 protein kinases: Map positions and in vivo expression Genomics. 46: 379-388. PMID 9441741 DOI: 10.1006/Geno.1997.5068  0.332
1997 Dang CV, Lewis BC, Dolde C, Dang G, Shim H. Oncogenes in tumor metabolism, tumorigenesis, and apoptosis Journal of Bioenergetics and Biomembranes. 29: 345-354. PMID 9387095 DOI: 10.1023/A:1022446730452  0.49
1997 Wechsler DS, Shelly CA, Petroff CA, Dang CV. MXI1, a putative tumor suppressor gene, suppresses growth of human glioblastoma cells. Cancer Research. 57: 4905-12. PMID 9354456  0.345
1997 Shim H, Lewis BC, Dolde C, Li Q, Wu CS, Chun YS, Dang CV. Myc target genes in neoplastic transformation Current Topics in Microbiology and Immunology. 224: 181-190. PMID 9308241 DOI: 10.1007/978-3-642-60801-8_18  0.415
1997 Lee LA, Dang CV. C-Myc transrepression and cell transformation Current Topics in Microbiology and Immunology. 224: 131-135. PMID 9308236 DOI: 10.1007/978-3-642-60801-8_13  0.391
1997 Lewis BC, Shim H, Li Q, Wu CS, Lee LA, Maity A, Dang CV. Identification of putative c-Myc-responsive genes: Characterization of rcl, a novel growth-related gene Molecular and Cellular Biology. 17: 4967-4978. PMID 9271375 DOI: 10.1128/Mcb.17.9.4967  0.423
1997 Alvarez RJ, Gips SJ, Moldovan N, Wilhide CC, Milliken EE, Hoang AT, Hruban RH, Silverman HS, Dang CV, Goldschmidt-Clermont PJ. 17β-estradiol inhibits apoptosis of endothelial cells Biochemical and Biophysical Research Communications. 237: 372-381. PMID 9268719 DOI: 10.1006/Bbrc.1997.7085  0.314
1997 Yano T, Nakamura T, Blechman J, Sorio C, Dang CV, Geiger B, Canaani E. Nuclear punctate distribution of ALL-1 is conferred by distinct elements at the N terminus of the protein Proceedings of the National Academy of Sciences of the United States of America. 94: 7286-7291. PMID 9207083 DOI: 10.1073/Pnas.94.14.7286  0.322
1997 Shim H, Dolde C, Lewis BC, Wu CS, Dang G, Jungmann RA, Dalla-Favera R, Dang CV. c-Myc transactivation of LDH-A: Implications for tumor metabolism and growth Proceedings of the National Academy of Sciences of the United States of America. 94: 6658-6663. PMID 9192621 DOI: 10.1073/Pnas.94.13.6658  0.455
1997 Dang CV, Lewis BC. Role of oncogenic transcription factor c-Myc in cell cycle regulation, apoptosis and metabolism Journal of Biomedical Science. 4: 269-278. DOI: 10.1007/Bf02258350  0.491
1996 Wechsler DS, Shelly CA, Dang CV. Genomic organization of human MXI1, a putative tumor suppressor gene. Genomics. 32: 466-70. PMID 8838813 DOI: 10.1006/Geno.1996.0144  0.339
1996 Cohen KJ, Hanna JS, Prescott JE, Dang CV. Transformation by the Bmi-1 oncoprotein correlates with its subnuclear localization but not its transcriptional suppression activity Molecular and Cellular Biology. 16: 5527-5535. PMID 8816465 DOI: 10.1128/Mcb.16.10.5527  0.336
1996 Semmes OJ, Barrett JF, Dang CV, Jeang KT. Human T-cell leukemia virus type I Tax masks c-Myc function through a cAMP-dependent pathway Journal of Biological Chemistry. 271: 9730-9738. PMID 8621651 DOI: 10.1074/Jbc.271.16.9730  0.418
1996 Lee LA, Dolde C, Barrett J, Wu CS, Dang CV. A link between c-Myc-mediated transcriptional repression and neoplastic transformation Journal of Clinical Investigation. 97: 1687-1695. PMID 8601634 DOI: 10.1172/Jci118595  0.394
1995 Wang HD, Yuh CH, Dang CV, Johnson DL. The hepatitis B virus X protein increases the cellular level of TATA-binding protein, which mediates transactivation of RNA polymerase III genes Molecular and Cellular Biology. 15: 6720-6728. PMID 8524237 DOI: 10.1128/Mcb.15.12.6720  0.57
1995 Lee LA, Resar LMS, Dang CV. Cell density and paradoxical transcriptional properties of c-Myc and Max in cultured mouse fibroblasts Journal of Clinical Investigation. 95: 900-904. PMID 7860774 DOI: 10.1172/Jci117741  0.414
1995 Chou TY, Dang CV, Hart GW. Glycosylation of the c-Myc transactivation domain Proceedings of the National Academy of Sciences of the United States of America. 92: 4417-4421. PMID 7753821 DOI: 10.1073/Pnas.92.10.4417  0.328
1995 Chou TY, Hart GW, Dang CV. c-Myc is glycosylated at threonine 58, a known phosphorylation site and a mutational hot spot in lymphomas Journal of Biological Chemistry. 270: 18961-18965. PMID 7642555 DOI: 10.1074/Jbc.270.32.18961  0.366
1995 Hoang AT, Lutterbach B, Lewis BC, Yano T, Chou TY, Barrett JF, Raffeld M, Hann SR, Dang CV. A link between increased transforming activity of lymphoma-derived MYC mutant alleles, their defective regulation by p107, and altered phosphorylation of the c-myc transactivation domain Molecular and Cellular Biology. 15: 4031-4042. PMID 7623799 DOI: 10.1128/Mcb.15.8.4031  0.368
1995 Barrett JF, Lewis BC, Hoang AT, Alvarez RJ, Dang CV. Cyclin A links c-Myc to adhesion-independent cell proliferation Journal of Biological Chemistry. 270: 15923-15925. PMID 7608142 DOI: 10.1074/Jbc.270.27.15923  0.408
1994 Gu W, Bhatia K, Magrath IT, Dang CV, Dalla-Favera R. Binding and suppression of the Myc transcriptional activation domain by p107 Science. 264: 251-254. PMID 8146655 DOI: 10.1126/Science.8146655  0.358
1994 Hoang AT, Cohen KJ, Barrett JF, Bergstrom DA, Dang CV. Participation of cyclin A in Myc-induced apoptosis Proceedings of the National Academy of Sciences of the United States of America. 91: 6875-6879. PMID 8041712 DOI: 10.1073/Pnas.91.15.6875  0.373
1994 Navankasattusas S, Sawadogo M, Van Bilsen M, Dang CV, Chien KR. The basic helix-loop-helix protein upstream stimulating factor regulates the cardiac ventricular myosin light-chain 2 gene via independent cis regulatory elements Molecular and Cellular Biology. 14: 7331-7339. PMID 7935447 DOI: 10.1128/Mcb.14.11.7331  0.323
1994 Raffeld M, Yano T, Hoang AT, Lewis B, Clark HM, Otsuki T, Dang CV. Clustered mutations in the transcriptional activation domain of Myc in 8q24 translocated lymphomas and their functional consequences Current Topics in Microbiology and Immunology. 194: 265-272. PMID 7895498 DOI: 10.1007/978-3-642-79275-5_31  0.311
1993 Resar LMS, Dolde C, Barrett JF, Dang CV. B-Myc Inhibits Neoplastic Transformation and Transcriptional Activation by c-Myc Molecular and Cellular Biology. 13: 1130-1136. PMID 8423780 DOI: 10.1128/Mcb.13.2.1130  0.407
1992 Dang CV, Dolde C, Gillison ML, Kato GJ. Discrimination between related DNA sites by a single amino acid residue of Myc-related basic-helix-loop-helix proteins Proceedings of the National Academy of Sciences of the United States of America. 89: 599-602. PMID 1731330 DOI: 10.1073/Pnas.89.2.599  0.3
1992 Kato GJ, Lee WMF, Chen L, Dang CV. Max: Functional domains and interaction with c-Myc Genes and Development. 6: 81-92. PMID 1730412 DOI: 10.1101/Gad.6.1.81  0.353
1992 Barrett J, Birrer MJ, Kato GJ, Dosaka-Akita H, Dang CV. Activation domains of L-Myc and c-Myc determine their transforming potencies in rat embryo cells Molecular and Cellular Biology. 12: 3130-3137. PMID 1620120 DOI: 10.1128/Mcb.12.7.3130  0.358
1992 Kato GJ, Dang CV. Function of the c-Myc oncoprotein Faseb Journal. 6: 3065-3072. PMID 1521738 DOI: 10.1096/Fasebj.6.12.1521738  0.403
1992 Kato GJ, Wechsler DS, Dang CV. DNA binding by the Myc oncoproteins. Cancer Treatment and Research. 63: 313-25. PMID 1363364 DOI: 10.1007/978-1-4615-3088-6_16  0.441
1992 Wechsler DS, Dang CV. Opposite orientations of DNA bending by c-Myc and Max. Proceedings of the National Academy of Sciences of the United States of America. 89: 7635-9. PMID 1323849 DOI: 10.1073/Pnas.89.16.7635  0.34
1991 Dang CV, Barrett J, Villa-Garcia M, Resar LMS, Kato GJ, Fearon ER. Intracellular Leucine Zipper Interactions Suggest c-Myc Hetero-Oligomerization Molecular and Cellular Biology. 11: 954-962. PMID 1990293 DOI: 10.1128/Mcb.11.2.954  0.339
1991 Dang CV. c-Myc oncoprotein function Bba - Reviews On Cancer. 1072: 103-113. PMID 1751543 DOI: 10.1016/0304-419X(91)90009-A  0.407
1990 Kato GJ, Barrett J, Villa-Garcia M, Dang CV. An amino-terminal c-Myc domain required for neoplastic transformation activates transcription Molecular and Cellular Biology. 10: 5914-5920. PMID 2233723 DOI: 10.1128/Mcb.10.11.5914  0.398
1989 Dang CV, Van Dam H, Buckmire M, Lee WMF. DNA-binding domain of human c-myc produced in Escherichia coli Molecular and Cellular Biology. 9: 2477-2486. PMID 2668734 DOI: 10.1128/Mcb.9.6.2477  0.325
1989 Dang CV, McGuire M, Buckmire M, Lee WMF. Involvement of the 'leucine zipper' region in the oligomerization and transforming activity of human c-myc protein Nature. 337: 664-666. PMID 2645525 DOI: 10.1038/337664A0  0.374
1989 Dang CV. Oncogenes and proto-oncogenes: General concepts Cancer Treatment and Research. 47: 1-24. DOI: 10.1007/978-1-4613-1599-5_1  0.411
1988 Dang CV, Lee WMF. Identification of the human c-myc protein nuclear translocation signal Molecular and Cellular Biology. 8: 4048-4054. PMID 3054508 DOI: 10.1128/Mcb.8.10.4048  0.305
1986 Dang CV. Higher eukaryotic aminoacyl-tRNA synthetases in physiologic and pathologic states Molecular and Cellular Biochemistry. 71: 107-120. PMID 3534543 DOI: 10.1007/Bf00214769  0.357
Show low-probability matches.